Find our #healthcare and #pharmaceutical #consulting services on #fiverr https://lnkd.in/gFQAhzJQ Our services include - Competitive intelligence - Pipeline reports - Market research - Market access - Forecasting - Excel dashboards
iPharmaCenter
Internet News
Varanasi, Uttar Pradesh 865 followers
iPharmaCenter is a single stop where you can find the latest #healthcare and #pharmaceutical #news at one place
About us
iPharmaCenter is a website which publishes drug approvals across the #world. It covers #healthcare updates and provides all the #patients relevant information. Find the approvals from the #US #FDA #EMA #TGA #HealthCanada and many more at one place
- Website
-
http://www.ipharmacenter.com
External link for iPharmaCenter
- Industry
- Internet News
- Company size
- 2-10 employees
- Headquarters
- Varanasi, Uttar Pradesh
- Type
- Privately Held
Locations
-
Primary
Get directions
Varanasi Bypass
Varanasi, Uttar Pradesh, IN
Updates
-
Updated Analysis of #Kisqali in NATALEE Trial Demonstrates Lasting Reduction in Distant Recurrence for Early #BreastCancer Patients https://lnkd.in/g9z9NZA3 #pharma #pharmaceutical #Science #SABCS24 #SABCS #news #media #Oncology #breaking #Cancer #Oncologist #healthcare
-
#Genentech's Fixed-Duration Therapy #Columvi and #Lunsumio Showed Promise in #Lymphoma Patients https://lnkd.in/gVbUCJ2m #pharma #pharmaceutical #Science #breakingnews #news #media #medicine #VTP #VTP2025 #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology #breaking
-
#Lilly's pirtobrutinib showed a significant reduction in disease progression or death in CLL or SLL patients https://lnkd.in/gVbUCJ2m #pharma #pharmaceutical #Science #breakingnews #news #media #medicine #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology #breaking
-
RWE Results for 2L #Yescarta Therapy in Patients With Relapsed/Refractory Large B-Cell #Lymphoma https://lnkd.in/g7DJV2NF #pharma #pharmaceutical #Science #breakingnews #news #media #medicine #VTP #VTP2025 #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology #breaking
-
#Merck’s #ZilovertamabVedotin Combined With R-CHP Achieves 100% Complete Response in Ph2 Trial for Untreated Diffuse Large B-Cell #Lymphoma https://lnkd.in/g7DJV2NF #pharma #pharmaceutical #breakingnews #news #medicine #VTP #VTP2025 #Hematologia #ASH24 #ASHaiku #ASH25 #hematology
American Society of Hematology (ASH) Annual Meeting | News | Updates | 2024 | iPharmaCenter
ipharmacenter.com
-
Extended Data for Scemblix Demonstrates Superior Efficacy in Newly Diagnosed #CML https://lnkd.in/g7DJV2NF #pharma #pharmaceutical #Science #breakingnews #news #media #medicine #VTP #VTP2025 #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology #breaking
-
Extended Data for Scemblix Demonstrates Superior Efficacy and Favorable Safety in Newly Diagnosed #CML https://lnkd.in/g7DJV2NF #pharma #pharmaceutical #Science #TeleMedicine #news #media #medicine #VTP #VTP2025 #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology
American Society of Hematology (ASH) Annual Meeting | News | Updates | 2024 | iPharmaCenter
ipharmacenter.com
-
#Blenrep Shows Notable Survival Advantage, Cutting Death Risk by 42% in Relapsed #MultipleMyeloma https://lnkd.in/g7DJV2NF #pharma #pharmaceutical #Science #TeleMedicine #news #media #medicine #VTP #VTP2025 #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology
American Society of Hematology (ASH) Annual Meeting | News | Updates | 2024 | iPharmaCenter
ipharmacenter.com
-
#Blenrep Shows Notable Survival Advantage, Cutting Death Risk by 42% in Relapsed #MultipleMyeloma https://lnkd.in/gqdFw2c8 #pharma #pharmaceutical #Science #TeleMedicine #news #media #medicine #ASH2024 #ASH24 #hematology #breaking #breakingnews #GSK #GSKNews